To evaluate the anti-aging effects of fisetin on Tert-deficient progeria mice, we randomly divided WT and G3 Tert−/− mice into vehicle and fisetin-treated groups, administering fisetin orally continuously and intermittently via gavage (Fig. 2A). The gene discussed is TERT; the disease is progeroid syndrome.